Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Karen L. Reckamp, MD, is Director of the Division of Medical Oncology at Cedars-Sinai Cancer. She also serves as Medical Oncology Director of the Women’s Guild Lung Institute in Cedars-Sinai's Department of Medicine and as Associate Director for Clinical Research at Cedars-Sinai Cancer. She joined the Cedars-Sinai faculty in January 2020, after holding several posts at City of Hope.
Dr. Reckamp is nationally recognized for her trailblazing research in advancing treatments and therapies for lung cancer – particularly the most advanced and difficult-to-treat cases – and her distinguished record of clinical research and scholarship.
In her role as Assistant Director for Clinical Research, Dr. Reckamp is guiding the growth of cancer clinical research services across the Cedars-Sinai Health System and is developing a robust Cedars-Sinai Cancer clinical trial portfolio.
As Medical Oncology Director in the Lung Institute, Dr. Reckamp is developing and overseeing a lung cancer curriculum for the institute and integrating clinical care with research. She serves as Co-Director of the Lung Cancer Tumor Board.
Reckamp earned her medical degree from the University of Chicago's Pritzker School of Medicine. She completed her internship and residency, both in internal medicine, at Barnes-Jewish Hospital in St. Louis, followed by a fellowship in hematology/oncology and a master's degree in clinical research at UCLA. She is the recipient of more than a dozen national honors, scholarships, and awards, including the STOP Cancer Carrie Scott Memorial Grant in 2018. Her research has been published in numerous academic medical journals, including The New England Journal of Medicine.